U.S. pharma large copyright scrapped two experimental weight loss supplements final 12 months—a as soon as-daily pill, lotiglipron, because of elevated liver enzymes along with a twice-daily pill, danuglipron, due to potent side effects—but CEO Albert Bourla has mentioned the company is set to “Enjoy and gain” from the weight problems House